Display options
Cite
Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol. 1986;89(3):563-71doi: 10.1111/j.1476-5381.1986.tb11157.x.
Martin, W., Smith, J. A., & White, D. G. (1986). The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. British journal of pharmacology, 89(3), 563-71. https://doi.org/10.1111/j.1476-5381.1986.tb11157.x
Martin, W, et al. "The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor." British journal of pharmacology vol. 89,3 (1986): 563-71. doi: https://doi.org/10.1111/j.1476-5381.1986.tb11157.x
Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol. 1986 Nov;89(3):563-71. doi: 10.1111/j.1476-5381.1986.tb11157.x. PMID: 3099876; PMCID: PMC1917156.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1986 Nov;89(3):563-71. doi: 10.1111/j.1476-5381.1986.tb11157.x.

The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor.

British journal of pharmacology

W Martin, J A Smith, D G White

PMID: 3099876 PMCID: PMC1917156 DOI: 10.1111/j.1476-5381.1986.tb11157.x
Free PMC Article

Abstract

The mechanisms by which haemoglobin and methaemoglobin inhibit the vasodilator actions of glyceryl trinitrate, sodium azide, nitric oxide, and the bovine retractor penis inhibitory factor (IF) were studied on rabbit endothelium-denuded aortic rings. Methaemoglobin was less effective than haemoglobin against each vasodilator, it was more effective at inhibiting the relaxation to azide than that to glyceryl trinitrate. Glyceryl trinitrate was neither bound nor inactivated when passed through columns of haemoglobin-agarose or methaemoglobin-agarose. Azide was reversibly bound but less by haemoglobin-agarose than by methaemoglobin-agarose. Inhibition of the vasodilator actions of glyceryl trinitrate is not attributable therefore to a direct interaction with the haemoproteins, although a small part of the inhibition of azide-induced relaxation by methaemoglobin is likely to be due to a direct interaction. Columns of haemoglobin-agarose were more effective than columns of methaemoglobin-agarose in removing nitric oxide from solution. The greater ability of haemoglobin, compared to methaemoglobin, to inhibit vasodilatation induced by nitrovasodilators may therefore reflect the greater ability of haemoglobin to bind nitric oxide which is the active principle of the nitrovasodilators. Neither the acid-activated nor the inactive forms of IF were bound or inactivated when passed through columns of methaemoglobin-agarose. Neither form of IF was retained on passage through columns of haemoglobin-agarose, but the resulting activity in the eluates was less than control, was unstable and, unlike the original activity, decayed rapidly on ice. The greater ability of haemoglobin, compared to methaemoglobin, to inhibit vasodilatation induced by IF might therefore reflect the greater ability of haemoglobin to interact with this vasodilator and inactivate it.

Similar articles

Menzies JA.
J Physiol. 1895 Apr 06;17(6):402-14. doi: 10.1113/jphysiol.1895.sp000547.
PMID: 16992193

Show all 11 similar articles

References

  1. Br J Pharmacol. 1975 Jul;54(3):409-10 - PubMed
  2. J Physiol. 1957 May 23;136(3):507-24 - PubMed
  3. J Cyclic Nucleotide Res. 1977 Feb;3(1):23-35 - PubMed
  4. Nature. 1977 Feb 24;265(5596):750-1 - PubMed
  5. Biochem Biophys Res Commun. 1977 Apr 25;75(4):851-6 - PubMed
  6. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3203-7 - PubMed
  7. J Biol Chem. 1978 Dec 10;253(23):8433-43 - PubMed
  8. Br J Pharmacol. 1979 Nov;67(3):327-8 - PubMed
  9. J Pharmacol Exp Ther. 1980 Jul;214(1):9-15 - PubMed
  10. Nature. 1980 Nov 27;288(5789):373-6 - PubMed
  11. J Physiol. 1980 Dec;309:55-64 - PubMed
  12. Eur J Biochem. 1981 Jun 1;116(3):479-86 - PubMed
  13. FEBS Lett. 1981 Sep 14;132(1):71-4 - PubMed
  14. J Physiol. 1981 Jun;315:111-25 - PubMed
  15. Arch Biochem Biophys. 1982 Oct 1;218(1):187-98 - PubMed
  16. Eur J Pharmacol. 1982 Nov 19;85(2):221-4 - PubMed
  17. Circ Res. 1983 Mar;52(3):352-7 - PubMed
  18. Biochem J. 1983 Dec 1;215(3):447-55 - PubMed
  19. Nature. 1984 Apr 12-18;308(5960):645-7 - PubMed
  20. Br J Pharmacol. 1984 Apr;81(4):665-74 - PubMed
  21. Trans Assoc Am Physicians. 1983;96:19-30 - PubMed
  22. J Pharmacol Exp Ther. 1985 Mar;232(3):708-16 - PubMed
  23. J Cell Physiol. 1985 Jun;123(3):310-20 - PubMed
  24. J Pharmacol Exp Ther. 1985 Jun;233(3):679-85 - PubMed
  25. Basic Res Cardiol. 1985 Sep-Oct;80(5):475-90 - PubMed
  26. J Cyclic Nucleotide Res. 1975;1(6):261-9 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources